ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Visitor Policy; Support Us.

[LCID Study Number: 2015-030]

NRG-BR002: A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

The purpose of this study is to compare any good or bad effects of delivering ablative local therapy to ALL known metastatic tumor sites, (even those that are not causing symptoms); in addition to the usual approach of intravenous or oral medications for treatment of breast cancer that has spread to up to 4 body sites.

Disease/Condition: Breast Cancer

Department: Radiation Oncology

Status: Active, Not Recruiting

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Lahey Lexington; Lahey Arlington; Lahey Nashua

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421